Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Operating Income Performance
Trending higher, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$81.67M
Near historical average
Average (9y)
$84.67M
Historical baseline
Range
High:$173.70M
Low:$-5.27M
CAGR
+18.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $81.67M | +1649.9% |
| 2023 | $-5.27M | -111.4% |
| 2022 | $46.12M | -46.4% |
| 2021 | $86.03M | -50.5% |
| 2020 | $173.70M | +16.9% |
| 2019 | $148.57M | +2.9% |
| 2018 | $144.44M | +45.1% |
| 2017 | $99.54M | +83.6% |
| 2016 | $54.22M | +206.9% |
| 2015 | $17.66M | - |